28. This frail patient has recurrent, resistant TTP with cerebral
involvement. He is due to start rituximab after having high dose
steroids, immunosuppressants, PLEX and TTP. He has a high urea which
is a concern given his steroid use and the possibility of GI bleeding. He
is clearly at high risk of infection and we will actively monitor for this.
Given his challenges and no evidence of seizures on an EEG, a
tracheostomy may be needed but will need to be carefully timed.
Given the benefits and burdens of this in the context of his illness and
treatments, and that he is now starting to follow some commands, we
will consider this carefully over the coming week.